Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engensis in painful diabetic peripheral neuropathy
NCT04469270Phase 3Completed
- Sponsor
- Helixmith
- Start
- Nov 2020
- Primary completion
- Mar 2023
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 1
01
Overview
A Phase 3 trial of Engensis in diabetic peripheral neuropathy (DPN), sponsored by Helixmith. Started Nov 2020; status: completed.
02
Drugs
Engensis
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04469270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469270.